Ketogenic diet modulates gut microbiota composition in an experimental model of cerebral palsy
Authors:
- Jakssuel Sebastion Dantas AlvesJAJakssuel Sebastion Dantas Alves
- Nathalia Caroline De Oliveira MeloNMNathalia Caroline De Oliveira Melo
- Ana Elisa ToscanoATAna Elisa Toscano
- Raul Manhães-De-CastroRMRaul Manhães-De-Castro
- José Patrocínio Ribeiro Cruz NetoJNJosé Patrocínio Ribeiro Cruz Neto
- José Luiz De Brito AlvesJAJosé Luiz De Brito Alves
- 24 April 2026
- journal article
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 29 (11) , 1346-1356
Abstract
Cerebral palsy (CPa) is a neurodevelopmental disorder often accompanied by gastrointestinal dysfunction and dysbiosis of the gut microbiota (GM). The ketogenic diet (KD) has demonstrated neuroprotective and anti-inflammatory properties in neurological diseases, yet its effects on GM in CPa remain poorly understood. This study aimed to evaluate the impact of KD on the GM composition in an experimental model of CPa. Male Wistar rats were assigned to four groups (n = 10) according to healthy status and KD intervention: healthy control (C), healthy ketogenic diet (K), cerebral palsy (P), and cerebral palsy with ketogenic diet (PK). CPa was induced by perinatal anoxia and sensorimotor restriction, and, from postnatal day 25-65, animals received a standard or a KD. Body weight, food, and energy intake were monitored. Fecal samples were collected at day 65 for 16S rRNA sequencing and bioinformatics analyses. The CPa condition was associated with reduced body weight, decreased food intake, and marked alterations in GM composition, characterized by increased abundance of Proteobacteria, Enterobacteriaceae, and Escherichia-Shigella, along with reduced levels of Bifidobacterium and Lactobacillus. KD intervention in animals with CPa was associated with coordinated shifts in GM structure, including reduced representation of taxa linked to inflammatory profiles and increased abundance of short-chain fatty acid-producing bacterial groups, such as members of the Lachnospiraceae and Ruminococcaceae families. Overall, these findings suggest that modulation of GM may contribute to the neuroprotective and anti-inflammatory effects of the KD, highlighting GM as a potential therapeutic target for CPa-associated comorbidities.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 33 references indexed in Scilit:
- A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolitesCell, 2024
- GDF15 is a major determinant of ketogenic diet-induced weight lossCell Metabolism, 2023
- Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial DiversityJAMA Network Open, 2021
- Human gut microbiota/microbiome in health and diseases: a reviewAntonie van Leeuwenhoek, 2020
- Ketogenic diet and NeuroinflammationEpilepsy Research, 2020
- The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic DietCell, 2018
- Ketogenic diet guidelines for infants with refractory epilepsyEuropean Journal of Paediatric Neurology, 2016
- Effects of maternal low‐protein diet on parameters of locomotor activity in a rat model of cerebral palsyInternational Journal of Developmental Neuroscience, 2016
- Impact of neonatal asphyxia and hind limb immobilization on musculoskeletal tissues and S1 map organization: Implications for cerebral palsyExperimental Neurology, 2008
- Effects of sensorimotor restriction and anoxia on gait and motor cortex organization: Implications for a rodent model of cerebral palsyNeuroscience, 2004